Cancer Health Treatment Update Immunotherapy Shows Promise for Early Lung Cancer Tecentriq after surgery and chemotherapy delayed recurrence in people with Stage II or III non-small-cell lung cancer. Breast and Cervical Cancer Screenings Fell Sharply During COVID-19 Crisis Prolonged delays in cancer screening for low-income women during to the pandemic threaten to increase existing health disparities. How RNA-Altering Drugs Might Improve Anticancer Immunotherapies In a lab study, brief disruptions of gene machinery make tumor cells more "visible" to immune system. Oncologists Underestimate How Many Breast Cancer Patients Use Complementary Medicine Nearly three fourths of breast cancer patients employed one or more complementary therapies during treatment. Advertisement Some Young Adult Cancer Survivors Are Hesitant About COVID-19 Vaccines These findings, however, may reflect regional attitudes in Utah and the surrounding area. More News About COVID-19 See all Cancer Health coverage of COVID-19, including how it affects people living with cancer. For more news about the SARS-CoV-2 coronavirus, visit our sister site, COVID Health.com. Cancer Health Summer 2021 Check out our latest print edition! Newsfeed Gene in Black People Can Result in Needless Bone Marrow Biopsies Ciara Urges Black Women to Get Screened for Cervical Cancer Oncologists Underestimate the Number of Breast Cancer Patients Who Use Complementary Medicine Cancer Survivors and Physical Activity: What’s New? Blog: Food and Drug Administration (FDA) FDA Approves Rylaze for Leukemia and Lymphoma FDA Encourages Inclusion of People With Incurable Cancers in Clinical Trials FDA Ayvakit for Advanced Systemic Mastocytosis FDA Approves Truseltiq for Metastatic Cholangiocarcinoma Newsfeed Gene in Black People Can Result in Needless Bone Marrow Biopsies Ciara Urges Black Women to Get Screened for Cervical Cancer Oncologists Underestimate the Number of Breast Cancer Patients Who Use Complementary Medicine Cancer Survivors and Physical Activity: What’s New? Blog: Food and Drug Administration (FDA) FDA Approves Rylaze for Leukemia and Lymphoma FDA Encourages Inclusion of People With Incurable Cancers in Clinical Trials FDA Ayvakit for Advanced Systemic Mastocytosis FDA Approves Truseltiq for Metastatic Cholangiocarcinoma

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: